| Authors: |
De Meerleer G; Department of Radiation Oncology, University Hospitals Leuven, Leuven, Belgium. Electronic address: gert.demeerleer@uzleuven.be., Berghen C; Department of Radiation Oncology, University Hospitals Leuven, Leuven, Belgium., Briganti A; Department of Urology, IRCCS Ospedale San Raffaele, Milan, Italy., Vulsteke C; Department of Medical Oncology, Maria Middelares Hospital, Gent, Belgium., Murray J; Department of Radiation Oncology, Royal Marsden NHS Foundation Trust, London, UK., Joniau S; Department of Urology, University Hospitals Leuven, Leuven, Belgium., Leliveld AM; Department of Urology, University Medical Centre Groningen, Groningen, Netherlands., Cozzarini C; Department of Radiation Oncology, IRCCS Ospedale San Raffaele, Milan, Italy., Decaestecker K; Department of Urology, Gent University Hospital, Gent, Belgium., Rans K; Department of Radiation Oncology, University Hospitals Leuven, Leuven, Belgium., Fonteyne V; Department of Radiotherapy and Experimental Cancer Research, Gent University Hospital, Gent, Belgium., De Hertogh O; Department of Radiotherapy, Centre Hospitalier Régional de Verviers, Verviers, Belgium., Bossi A; Department of Radiation Oncology, Gustave Roussy Institute, Paris, France. |
